Developer docs
API playgroundTry for free, no card

Search company profiles

AYMES

Full company profile

uuid000hs9d

Namestring
AYMES
Legal namestring
AYMES International Limited
Websiteurl
aymes.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

AYMES International Limited is a UK-based private manufacturer of Oral Nutritional Supplements (ONS) used in the management of disease-related malnutrition. Founded in 2013 and registered in England and Wales (Company No. 06603123), the company is headquartered in Leek, Staffordshire, with a secondary office in Dublin, Ireland, and operates as a remote-first organisation with approximately 30 employees across the UK and Europe.

The company's product range centres on two platforms: ActaGain, a ready-to-drink and ready-to-eat range priced at 99p per unit for the 1.5 Complete SKU from December 2025, and ActaSolve, a powdered format. It also offers the ActaJuni pediatric line and plant-based variants. Products are ACBS-approved for NHS prescribing and are dispensed through the FP10/GP10 prescription system, supported by a 48-hour free sample service for clinicians and the AYMES Academy education platform.

AYMES monetises almost exclusively via NHS prescriptions across UK Clinical Commissioning Groups, with secondary activity in Ireland. It positions itself on cost-effectiveness — citing 8p per gram of protein for ActaGain Protein Compact versus 9–15p for competitors — and reports £230m of cumulative NHS savings from March 2013 to June 2025. Operational credentials include ISO 9001, ISO 14001, and B-Corp (June 2024) certifications, and the company was named in the Sunday Times Best Places to Work 2026.

Short descriptiontext

AYMES International Limited is a UK-based manufacturer of Oral Nutritional Supplements (ONS) for disease-related malnutrition, selling ACBS-approved products through NHS prescriptions and serving healthcare professionals in the UK and Ireland.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKensington, United Kingdom
HQ citystring
Kensington
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oral nutritional supplements, clinical nutrition products, disease-related malnutrition, NHS prescription supplements, medical nutrition manufacturing
Industry2 codes
PRIMARYCRADAGAN
Medical Nutrition & Meal Replacement (RTD, Bars, Powders)
SECONDARYAFAKAKAJ
Infant Formula & Specialized Dairy Nutrition Manufacturing
NAICS code2 codes
  • Dairy Product Manufacturing3115
  • Dairy Product (except Frozen) Manufacturing31151
SIC code2 codes
  • Food And Kindred Products2000
  • Dairy Products2020
Product category
Clinical Nutrition / Oral Nutritional Supplements
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1NHS Product Sales
TypeOne Time License
Description

AYMES oral nutritional supplements are sold to the NHS through prescription (FP10/GP10) and direct supply. Products are prescribed by healthcare professionals for patients with or at risk of disease-related malnutrition.

aymes.com
2Sample Service
TypeFreemium
Description

Free samples provided to healthcare professionals and patients to trial products before prescription. Available for fast, free delivery within 48 hours.

aymes.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Others
Pricing details2 tiers
1ActaGain 1.5 Complete - Ready-to-drink ONS
ModelUnit PricingBilling cadencePay-as-you-go
Notes

99p per unit (effective December 2025), starter pack at £4.88. Most cost-effective 1.5kcal/ml ready-to-drink ONS per gram of protein available.

aymes.com
2ActaGain Protein Compact - High protein, low-volume ONS
ModelUnit PricingBilling cadencePay-as-you-go
Notes

8p per gram of protein - most cost-effective protein ONS available. 20g protein, 320kcal in 125ml. ACBS approved on FP10/GP10.

aymes.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1ActaGain
Description

Product line for ready-to-drink and ready-to-eat oral nutritional supplements, including ActaGain 1.5 Complete, ActaGain 2.0, ActaGain 2.4, ActaGain Protein Compact, ActaGain Protein Shot, ActaGain Juce, and Actagain Creme.

aymes.com
+4 more records
Core offering1 text field

AYMES manufactures and supplies a comprehensive range of oral nutritional supplements (ONS) for the dietary management of disease-related malnutrition, organised under two main product families: ActaGain (ready-to-drink and ready-to-eat formats) and ActaSolve (powdered formats). Products are ACBS-approved for NHS prescribing and sold primarily through the NHS FP10/GP10 prescription system, supported by a free sample service for healthcare professionals and an educational platform (AYMES Academy).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • NHS cost savings of £230 million through use of cost-effective ONS products
+4 more records
Product overview1 text field

AYMES is a specialist producer of oral nutritional supplements (ONS) designed for the dietary management of disease-related malnutrition. The company offers a comprehensive portfolio organized under two main product families: ActaGain (ready-to-drink and ready-to-eat formats including compact bottles, juices, and cremes) and ActaSolve (powdered formats including milkshakes, savoury, smoothie, and protein variants). The product range spans various caloric densities (1.5-2.4 kcal/ml) and protein levels (including high-protein options like ActaGain Protein Compact with 20g protein per 125ml), with specialized products for paediatric patients (ActaJuni/Actajuni Shake) and plant-based options (Actagain 1.5 Plant Powered). AYMES serves primarily healthcare professionals and the NHS, offering professional education through AYMES Academy and product sampling services.

Product and service2 records
1ActaGain 1.5 Complete
CategoryCore Product - Oral Nutritional Supplement (Ready-to-drink)
Description

Highly prescribed ready-to-drink ONS providing 1.5kcal/ml, ACBS approved, available in Tetra Pak packaging for HCPs prescribing on FP10/GP10.

2ActaGain 1.5 Juce
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-06-11
Description

AYMES supports UNICEF through product donations as part of their charitable giving program, pledge 5% of profits to charitable causes in the UK.

2Tetra Pak
Strategic tierCoreTypeTechnology or Integration
Description

Partnership for sustainable packaging solutions. Tetra Pak cartons use 75% less plastic than standard ONS bottles, are made from 63% plant-based materials, and contribute to 11% reduction in carbon emissions.

aymes.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Food-first initiative partnership creating fortified food recipes (fortified porridge, soup, milkshake, pasta, custard) for patients to support nutritional intake through food-based approaches.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Charitable partnership through AYMES Give Back Day, supporting community food access initiatives.

5Dougie Mac Hospice
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Charitable partnership through AYMES Employee Charity Day, supporting hospice care.

aymes.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global medical nutrition leader whose Fresubin ONS portfolio (including Fresubin Pro Compact) directly competes with AYMES on NHS formularies. They are the primary benchmark AYMES compares pricing against.

TypeDirect peer
Description

Medical nutrition division of Danone producing Fortisip, the long-standing dominant UK ONS brand. Direct competitor on FP10/GP10 prescribing, with Fortisip Compact Protein priced at 15p/g protein in AYMES' comparison.

3Abbott Nutrition
TypeBroad incumbent
Description

Global healthcare giant with Ensure and Vital ONS ranges competing in the UK malnutrition market. Broader portfolio spanning pharmaceuticals, diagnostics, and nutrition creates overlap with AYMES in ONS.

TypeBroad incumbent
Description

Health-focused arm of Nestlé marketing Resource and Peptamen ONS, prominent in UK NHS prescribing. Comparable in addressing disease-related malnutrition with a wider portfolio and global R&D.

5Vitaflo
TypeDirect peer
Description

UK-based medical nutrition company focused on disease-specific and paediatric nutrition, ACBS-approved products on FP10/GP10. Direct competitor in NHS prescribable ONS and adjacent specialised nutrition.

TypeDirect peer
Description

Irish-founded ONS company producing compact and powdered oral nutritional supplements (e.g., Aymes-adjacent formats) prescribed across UK and Ireland. Comparable in product format, pricing strategy, and NHS distribution.

TypeEmerging player
Description

US-based plant-based medical nutrition company with oral and tube-feed formulas. Comparable in addressing disease-related malnutrition with plant-based formulations, though primarily US distribution.

TypeBroad incumbent
Description

Specialised nutrition subsidiary of Reckitt producing paediatric and metabolic nutrition products. Comparable in clinical nutrition positioning and ACBS-style prescribing channels.

TypeOthers
Description

B2B supplier of whey protein, milk minerals, and specialised dairy nutrition ingredients used in medical nutrition including ONS. Comparable as upstream supplier in the specialised dairy nutrition value chain.

10Abbott (Paediatric Nutrition)
TypeEmerging player
Description

Abbott's paediatric nutrition line (PediaSure, Similac) competes with AYMES' ActaJuni range in ACBS-approved feeds for children. Overlaps in paediatric ONS segment but broader paediatric scope.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AYMES

Clinical Nutrition / Oral Nutritional Supplementsaymes.com

AYMES International Limited is a UK-based manufacturer of Oral Nutritional Supplements (ONS) for disease-related malnutrition, selling ACBS-approved products through NHS prescriptions and serving healthcare professionals in the UK and Ireland.

What AYMES does

AYMES International Limited is a UK-based private manufacturer of Oral Nutritional Supplements (ONS) used in the management of disease-related malnutrition. Founded in 2013 and registered in England and Wales (Company No. 06603123), the company is headquartered in Leek, Staffordshire, with a secondary office in Dublin, Ireland, and operates as a remote-first organisation with approximately 30 employees across the UK and Europe.

The company's product range centres on two platforms: ActaGain, a ready-to-drink and ready-to-eat range priced at 99p per unit for the 1.5 Complete SKU from December 2025, and ActaSolve, a powdered format. It also offers the ActaJuni pediatric line and plant-based variants. Products are ACBS-approved for NHS prescribing and are dispensed through the FP10/GP10 prescription system, supported by a 48-hour free sample service for clinicians and the AYMES Academy education platform.

AYMES monetises almost exclusively via NHS prescriptions across UK Clinical Commissioning Groups, with secondary activity in Ireland. It positions itself on cost-effectiveness — citing 8p per gram of protein for ActaGain Protein Compact versus 9–15p for competitors — and reports £230m of cumulative NHS savings from March 2013 to June 2025. Operational credentials include ISO 9001, ISO 14001, and B-Corp (June 2024) certifications, and the company was named in the Sunday Times Best Places to Work 2026.

AYMES firmographics

Firmographics
Name
AYMES
Legal name
AYMES International Limited
Website
https://aymes.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
AYMES International Limited is a UK-based manufacturer of Oral Nutritional Supplements (ONS) for disease-related malnutrition, selling ACBS-approved products through NHS prescriptions and serving healthcare professionals in the UK and Ireland.
Ownership category
akta.pro rank

AYMES industry classification

Industry
Product category
Clinical Nutrition / Oral Nutritional Supplements
NAICS
Dairy Product Manufacturing (3115), Dairy Product (except Frozen) Manufacturing (31151)
SIC
Food And Kindred Products (2000), Dairy Products (2020)
akta.pro industry
PRIMARYCRADAGAN
Medical Nutrition & Meal Replacement (RTD, Bars, Powders)
SECONDARYAFAKAKAJ
Infant Formula & Specialized Dairy Nutrition Manufacturing

Keywords

  • Oral nutritional supplements
  • Clinical nutrition products
  • Disease-related malnutrition
  • NHS prescription supplements
  • Medical nutrition manufacturing

Where AYMES is headquartered

Location

Headquarters

HQ city
Kensington
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

AYMES business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. NHS Product Sales: AYMES oral nutritional supplements are sold to the NHS through prescription (FP10/GP10) and direct supply. Products are prescribed by healthcare professionals for patients with or at risk of disease-related malnutrition.
  2. Sample Service: Free samples provided to healthcare professionals and patients to trial products before prescription. Available for fast, free delivery within 48 hours.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goActaGain 1.5 Complete - Ready-to-drink ONS
Unit PricingPay-as-you-goActaGain Protein Compact - High protein, low-volume ONS

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

AYMES product offering

Product offering

Core offering

AYMES manufactures and supplies a comprehensive range of oral nutritional supplements (ONS) for the dietary management of disease-related malnutrition, organised under two main product families: ActaGain (ready-to-drink and ready-to-eat formats) and ActaSolve (powdered formats). Products are ACBS-approved for NHS prescribing and sold primarily through the NHS FP10/GP10 prescription system, supported by a free sample service for healthcare professionals and an educational platform (AYMES Academy).

Product overview

AYMES is a specialist producer of oral nutritional supplements (ONS) designed for the dietary management of disease-related malnutrition. The company offers a comprehensive portfolio organized under two main product families: ActaGain (ready-to-drink and ready-to-eat formats including compact bottles, juices, and cremes) and ActaSolve (powdered formats including milkshakes, savoury, smoothie, and protein variants). The product range spans various caloric densities (1.5-2.4 kcal/ml) and protein levels (including high-protein options like ActaGain Protein Compact with 20g protein per 125ml), with specialized products for paediatric patients (ActaJuni/Actajuni Shake) and plant-based options (Actagain 1.5 Plant Powered). AYMES serves primarily healthcare professionals and the NHS, offering professional education through AYMES Academy and product sampling services.

Differentiator

Problem solved

Functional benefit

Brands

  • ActaGain: Product line for ready-to-drink and ready-to-eat oral nutritional supplements, including ActaGain 1.5 Complete, ActaGain 2.0, ActaGain 2.4, ActaGain Protein Compact, ActaGain Protein Shot, ActaGain Juce, and Actagain Creme.
  • ActaSolve
  • ActaJuni
  • AYMES Academy
  • AYMES Research Hub

Products and services

  • ActaGain 1.5 Complete Highly prescribed ready-to-drink ONS providing 1.5kcal/ml, ACBS approved, available in Tetra Pak packaging for HCPs prescribing on FP10/GP10.
  • ActaGain 1.5 Juce

Quantifiable outcome

  • NHS cost savings of £230 million through use of cost-effective ONS products
  • +4 more outcomes

Companies that use AYMES

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

AYMES technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

AYMES partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered minor and core.

  • UNICEFminorStrategic or Co-development Partner · 11 June 2024AYMES supports UNICEF through product donations as part of their charitable giving program, pledge 5% of profits to charitable causes in the UK.
  • Tetra PakcoreTechnology or IntegrationPartnership for sustainable packaging solutions. Tetra Pak cartons use 75% less plastic than standard ONS bottles, are made from 63% plant-based materials, and contribute to 11% reduction in carbon emissions.
  • Nightingale Hammerson's ReachminorStrategic or Co-development PartnerFood-first initiative partnership creating fortified food recipes (fortified porridge, soup, milkshake, pasta, custard) for patients to support nutritional intake through food-based approaches.
  • The Bread and Butter ThingminorStrategic or Co-development PartnerCharitable partnership through AYMES Give Back Day, supporting community food access initiatives.
  • Dougie Mac HospiceminorStrategic or Co-development PartnerCharitable partnership through AYMES Employee Charity Day, supporting hospice care.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

AYMES competitors and assessment

Company assessment

Direct peers

  • Fresenius Kabi: Global medical nutrition leader whose Fresubin ONS portfolio (including Fresubin Pro Compact) directly competes with AYMES on NHS formularies. They are the primary benchmark AYMES compares pricing against.
  • Nutricia (Danone): Medical nutrition division of Danone producing Fortisip, the long-standing dominant UK ONS brand. Direct competitor on FP10/GP10 prescribing, with Fortisip Compact Protein priced at 15p/g protein in AYMES' comparison.
  • Vitaflo: UK-based medical nutrition company focused on disease-specific and paediatric nutrition, ACBS-approved products on FP10/GP10. Direct competitor in NHS prescribable ONS and adjacent specialised nutrition.
  • Nualtra: Irish-founded ONS company producing compact and powdered oral nutritional supplements (e.g., Aymes-adjacent formats) prescribed across UK and Ireland. Comparable in product format, pricing strategy, and NHS distribution.

Broad incumbents

  • Abbott Nutrition: Global healthcare giant with Ensure and Vital ONS ranges competing in the UK malnutrition market. Broader portfolio spanning pharmaceuticals, diagnostics, and nutrition creates overlap with AYMES in ONS.
  • Nestlé Health Science: Health-focused arm of Nestlé marketing Resource and Peptamen ONS, prominent in UK NHS prescribing. Comparable in addressing disease-related malnutrition with a wider portfolio and global R&D.
  • Mead Johnson (Reckitt): Specialised nutrition subsidiary of Reckitt producing paediatric and metabolic nutrition products. Comparable in clinical nutrition positioning and ACBS-style prescribing channels.

Emerging players

  • Kate Farms: US-based plant-based medical nutrition company with oral and tube-feed formulas. Comparable in addressing disease-related malnutrition with plant-based formulations, though primarily US distribution.
  • Abbott (Paediatric Nutrition): Abbott's paediatric nutrition line (PediaSure, Similac) competes with AYMES' ActaJuni range in ACBS-approved feeds for children. Overlaps in paediatric ONS segment but broader paediatric scope.

Others

  • Arla Foods Ingredients: B2B supplier of whey protein, milk minerals, and specialised dairy nutrition ingredients used in medical nutrition including ONS. Comparable as upstream supplier in the specialised dairy nutrition value chain.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

AYMES social profiles

Digital presence

AYMES compliance and trust

Trust signal

Compliance5 records

AYMES financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AYMES leadership team

Management profile

Number of profiles

Profiles3 records

AYMES funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AYMES M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AYMES

What does AYMES do?

AYMES manufactures and supplies a comprehensive range of oral nutritional supplements (ONS) for the dietary management of disease-related malnutrition, organised under two main product families: ActaGain (ready-to-drink and ready-to-eat formats) and ActaSolve (powdered formats). Products are ACBS-approved for NHS prescribing and sold primarily through the NHS FP10/GP10 prescription system, supported by a free sample service for healthcare professionals and an educational platform (AYMES Academy).

Is AYMES a public or private company?

AYMES is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was AYMES founded?

AYMES was founded in 2013. It employs 11 to 50 people.

Where is AYMES based?

AYMES is headquartered in Kensington, United Kingdom, in the Europe region.

How does AYMES make money?

Two revenue lines are on record. NHS Product Sales are the primary driver. The others are sample Service.

Who are AYMES's main competitors?

Direct peers on record are Fresenius Kabi, Nutricia (Danone), Vitaflo and Nualtra. Broad incumbents are Abbott Nutrition, Nestlé Health Science and Mead Johnson (Reckitt). Emerging players are Kate Farms and Abbott (Paediatric Nutrition). Arla Foods Ingredients is listed as an others.

Does AYMES have an API?

No public API is recorded for AYMES.

What industry is AYMES in?

AYMES's product category is Clinical Nutrition / Oral Nutritional Supplements. Its primary akta.pro industry code is CRADAGAN, Medical Nutrition & Meal Replacement (RTD, Bars, Powders), with a secondary code of AFAKAKAJ, Infant Formula & Specialized Dairy Nutrition Manufacturing. Its NAICS code is 3115 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals